References
- Baue, A.E., Durham, R., and Faist, E. 1998. Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): Are we winning the battle? Shock 10:79–89.
- Estabrook, R. 1996. The remarkable P450s: A historical overview of these versatile hemeprotein catalysts. FASEB J. 10:202–204.
- Eum, H.A., Yeom, D.H., and Lee, S. M. 2006. Role of nitric oxide in the inhibition of liver cytochrome P450 during sepsis. Nitric Oxide 15:423–431.
- Gonzalez, F., and Gelboin, H. 1994. Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab. Rev. 26:165–183.
- Guengerich, F. 1993. Cytochrome P450 enzymes. Am. Sci. 81:440–447.
- Halpert, J.R., Guengerich, F.P., Bend, J.R., and Correia, M.A. 1994. Contemporary issues in toxicology: Selective inhibitors of cytochromes P450. Toxicol. Appl. Pharmacol. 125:163–175.
- Iber, H., Sewer, M.B., Barclay, T.B., Mitchell, S.R., and Morgan, E.T. 1999. Modulation of drug metabolism in infectious and inflammatory diseases. Drug Metab. Rev. 31:29–41.
- Kraemer, M.J., Furukawa, C.T., Koup, J.R., Shapiro, G.G., Pierson, W.E., and Bierman, C.W. 1982. Altered theophylline clearance during an influenza B outbreak. Pediatrics 69:476–480.
- McKindley, D.S., Boulet, J., Sachdeva, K., Wang, P., and Chichester, C. 2002. Endotoxic shock alters the pharmacokinetics of lidocaine and monoethylglycinexylidide. Shock 17:199–204.
- Monshouwer, M., McLellan, R.A., Delaporte, E., Witkamp, R.F., van Miert, A.S., and Renton, K.W. 1996. Differential effect of pentoxifylline on lipopolysaccharide-induced down-regulation of cytochrome P450. Biochem. Pharmacol. 52:1195–1200.
- Morgan, E.T. 2001. Regulation of cytochrome P450 by inflammatory mediators: Why and how? Drug Metab. Dispos. 29:207–212.
- Moriya, K., Miura, N.N., Adachi, Y., and Ohno, N. 2002. Systemic inflammatory response associated with augmentation and activation of leukocytes in Candida/indomethacin-administered mice. Biol. Pharm. Bull. 25:816–822.
- Moriya, K., Ohno, N., Miura, N.N., Adachi, Y., and Yadomae, T. 2002. Septic shock induced by microbial products and indomethacin. Drug. Dev. Res. 55:139–148.
- Nameda, S., Saito, M., Miura, N.N., Adachi, Y., and Ohno, N. 2005. Effect of nitric oxide on β-glucan/indomethacin-induced septic shock. Biol. Pharm. Bull. 28:1254–1258.
- Shedlofsky, S.I., Israel, B.C., McClain, C.J., Hill, D.B., and Blouin, R.A. 1994. Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism. J. Clin. Invest. 94:2209–2214.
- Siewert, E., Bort, R., Kluge, R., Heinrich, P.C., and Jover, R. 2000. Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin-6-dependent. Hepatology 32:49–55.
- Takahashi, H., Ohno, N., Adachi, Y., and Yadomae, T. 2001. Association of immunological disorders in lethal side effect of NSAIDs on β-glucan-administered mice. FEMS. Immunol. Med. Microbiol. 31:1–14.
- Tu, W., Satoi, S., Zhang, Z., Kitade, H., Okumura, T., Kwon, A.H., and Kamiyama, Y. 2003. Hepatocellular dysfunction induced by nitric oxide production in hepatocytes isolated from rats with sepsis. Shock 19:373–377.
- Warren, G.W., Poloyac, S.M., Gary, D.S., Mattson, M.P., and Blouin, R.A. 1999. Hepatic cytochrome P450 expression in tumor necrosis factor-α receptor (p55/p75) knockout mice after endotoxin administration. J. Pharmacol. Exp. Ther. 288:945–950.
- Watkins, P. 1990. Role of cytochromes P450 in drug metabolism and hepatotoxicity. Sem. Liver Dis. 10:235–250.
- Yoshioka, S., Ohno, N., Miura, T., Adachi, Y., and Yadomae, T. 1998. Immunotoxicity of soluble β-glucans induced by indomethacin treatment. FEMS. Immunol. Med. Microbiol. 21:171–179.